Results 171 to 180 of about 5,531 (197)
Some of the next articles are maybe not open access.
Nonylphenyl methacrylate modified bisphenol‐a‐glycidyl dimethacrylate(BisGMA) networks
Pigment & Resin Technology, 2006PurposeTo evaluate the performance of a reactive diluent, nonylphenyl methacrylate (NPM) for toughness improvement of bisphenol‐a‐glycidyl dimethacrylate (BisGMA) and to optimise the results of such a modification.Design/methodology/approachTo achieve desirable rheological and physico‐mechanical properties of BisGMA/NPM network, various compositions ...
D. Behera, H. Satapathy, A.K. Banthia
openaire +1 more source
Cytotoxicity of bisphenol A glycidyl methacrylate on cytochrome P450‐producing cells
Journal of Oral Rehabilitation, 2003summary Of the cytochrome P450 (CYP) family of carcinogen‐activating enzymes, CYP3A is the major form found in human livers. The purpose of this study was to investigate the cytotoxic effects of dental resin monomers after being metabolized by CYP3A4 and CYP3A7, using a colony formation assay and a neutral red assay.
S, Hikage +7 more
openaire +2 more sources
Food and Chemical Toxicology, 2012
Bisphenol A-glycidyl-methacrylate (BisGMA), a dental composite resin and dentin bonding agent, might prompt inflammatory effects to adjacent tissues. Macrophages are a major cellular component of the inflammatory sites. Little is known about the mechanisms of BisGMA on macrophages activation.
Yu-Hsiang, Kuan +3 more
openaire +2 more sources
Bisphenol A-glycidyl-methacrylate (BisGMA), a dental composite resin and dentin bonding agent, might prompt inflammatory effects to adjacent tissues. Macrophages are a major cellular component of the inflammatory sites. Little is known about the mechanisms of BisGMA on macrophages activation.
Yu-Hsiang, Kuan +3 more
openaire +2 more sources
International Endodontic Journal, 2012
Kuan Y‐H, Li Y‐C, Huang F‐M, Chang Y‐C. The upregulation of tumour necrosis factor‐α and surface antigens expression on macrophages by bisphenol A‐glycidyl‐methacrylate. International Endodontic Journal, 45, 619–626, 2012.AbstractAim To evaluate the expression of tumour necrosis factor‐α and surface antigens by bisphenol A‐glycidyl‐methacrylate ...
Y-H, Kuan +3 more
openaire +2 more sources
Kuan Y‐H, Li Y‐C, Huang F‐M, Chang Y‐C. The upregulation of tumour necrosis factor‐α and surface antigens expression on macrophages by bisphenol A‐glycidyl‐methacrylate. International Endodontic Journal, 45, 619–626, 2012.AbstractAim To evaluate the expression of tumour necrosis factor‐α and surface antigens by bisphenol A‐glycidyl‐methacrylate ...
Y-H, Kuan +3 more
openaire +2 more sources
International Journal of Toxicology, 2013
The reproductive toxicity potential of the dental resin monomer bisphenol A glycidyl methacrylate (BisGMA; CASRN 1565-94-2) was investigated in male and female Crl: CD1(ICR) mice, 4 dosage groups, and 25 mice/sex/group. Formulations of BisGMA (0, 0.008, 0.08, or 0.8 mg/kg/d) in 0.8% ethanol in deionized water were intubated once daily beginning 28 ...
Lori H, Moilanen +2 more
openaire +2 more sources
The reproductive toxicity potential of the dental resin monomer bisphenol A glycidyl methacrylate (BisGMA; CASRN 1565-94-2) was investigated in male and female Crl: CD1(ICR) mice, 4 dosage groups, and 25 mice/sex/group. Formulations of BisGMA (0, 0.008, 0.08, or 0.8 mg/kg/d) in 0.8% ethanol in deionized water were intubated once daily beginning 28 ...
Lori H, Moilanen +2 more
openaire +2 more sources
The Bone & Joint Journal, 2019
AimsIn the 1990s, a bioactive bone cement (BABC) containing apatite-wollastonite glass-ceramic (AW-GC) powder and bisphenol-a-glycidyl methacrylate resin was developed at our hospital. In 1996, we used BABC to fix the acetabular component in primary total hip arthroplasty (THA) in 20 patients as part of a clinical trial.
K, Goto +4 more
openaire +2 more sources
AimsIn the 1990s, a bioactive bone cement (BABC) containing apatite-wollastonite glass-ceramic (AW-GC) powder and bisphenol-a-glycidyl methacrylate resin was developed at our hospital. In 1996, we used BABC to fix the acetabular component in primary total hip arthroplasty (THA) in 20 patients as part of a clinical trial.
K, Goto +4 more
openaire +2 more sources
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly